Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HCAR2 | Q8TDS4 | 10/20 | 0.53 |
| ▸ | TSHR | P16473 | 4/20 | 0.48 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.48 |
| ▸ | TP53 | P04637 | 2/20 | 0.48 |
| ▸ | HIF1A | Q16665 | 2/20 | 0.48 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.48 |
| ▸ | MAPT | P10636 | 1/20 | 0.43 |
| ▸ | CACNA1B | Q00975 | 1/20 | 0.43 |
| ▸ | APBA1 | Q02410 | 1/20 | 0.43 |
| ▸ | ATM | Q13315 | 1/20 | 0.38 |
| ▸ | THRB | P10828 | 2/20 | 0.38 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.35 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.33 |
| ▸ | APP | P05067 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4565814 | 1.00 | HCAR2 (0.53) | HCAR2TSHRALDH1A1TP53HIF1A | |
| SCHEMBL4449421 | 1.00 | HCAR2 (0.53) | HCAR2TSHRALDH1A1TP53HIF1A | |
| SCHEMBL4449423 | 0.92 | TSHR (0.56) | HCAR2TSHRALDH1A1TP53HIF1A | |
| SCHEMBL5854164 | 0.92 | TSHR (0.56) | HCAR2TSHRALDH1A1TP53HIF1A | |
| SCHEMBL5854151 | 0.92 | TSHR (0.56) | HCAR2TSHRALDH1A1TP53HIF1A | |
| SCHEMBL7637532 | 0.89 | HCAR2 (0.56) | HCAR2TSHRALDH1A1TP53HIF1A | |
| SCHEMBL7637527 | 0.89 | HCAR2 (0.56) | HCAR2TSHRALDH1A1TP53HIF1A | |
| SCHEMBL7636696 | 0.89 | HCAR2 (0.59) | HCAR2TSHRALDH1A1TP53HIF1A | |
| SCHEMBL7636698 | 0.89 | HCAR2 (0.59) | HCAR2TSHRALDH1A1TP53HIF1A | |
| SCHEMBL1082737 | 0.84 | MAPT (0.58) | HCAR2TSHRTP53MAPTCACNA1B |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7569327-B2 | Curable polymer compound | SHOWDA DENKO K.K. (JP) | 2009-08-04 | — | — | US | disclosed |
| EP-1629046-B1 | CURABLE POLYMER COMPOUND | SHOWA DENKO KK (JP) | 2008-05-14 | — | — | EP | disclosed |
| US-20070021571-A1 | Curable polymer compound | SHOWA DENKO K.K. (JP) | 2007-01-25 | — | — | US | disclosed |
| US-7049350-B2 | Polymerizable compound, polymerizable composition and cured product containing the compound | SHOWA DENKO K.K. (JP) | 2006-05-23 | — | — | US | disclosed |
| EP-1629046-A2 | CURABLE POLYMER COMPOUND | Showa Denko K.K. (JP) | 2006-03-01 | — | — | EP | disclosed |
| WO-2004106431-A2 | CURABLE POLYMER COMPOUND | SHOWA DENKO K.K. (JP) | 2004-12-09 | — | — | WO | disclosed |
| US-20040235980-A1 | Polymerizable compound, polymerizable composition and cured product containing the compound | SHOWA DENKO K.K. (JP) | 2004-11-25 | — | — | US | disclosed |
| WO-2003010124-A1 | POLYMERIZABLE COMPOUND, polymeRIZABLE COMPOSITION AND CURED PRODUCT CONTAINING THE COMPOUND | SHOWA DENKO K. K. (JP) | 2003-02-06 | — | — | WO | disclosed |
| EP-1176136-A1 | PROCESS FOR PRODUCING FUMARIC ESTER | Showa Denko K.K. (JP) | 2002-01-30 | — | — | EP | disclosed |
| US-20020002306-A1 | Method for producing fumaric acid esters | SHOWA DENKO K.K. (JP) | 2002-01-03 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20020002306-A1 | Method for producing fumaric acid esters | FH, ME1, ME3 | HCAR2 750/4885TSHR 4711/4885ALDH1A1 569/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.